HealthTrust selected Nanosphere to supply the tests for almost 1,400 acute care facilities under HealthTrust's membership. HealthTrust will offer its members the opportunity to purchase Nanosphere's Verigene tests, designed to detect infections in the bloodstream, respiratory tract and gastrointestinal tract.
The deal became effective on June 1.
Must Read: Warren Buffett's 25 Favorite Stocks
The stock was up 19.71% to $1.64 at 10:36 a.m.